Group press

releases

UbiPharm Group and HEC Paris celebrated, on Saturday, March 14, 2026 in Paris, the success of 18 executives who successfully completed the Executive Certificate in Strategic Management and Innovative Leadership, delivered by HEC Paris.

On March 14 and 15, 2026, UbiPharm Group, a leader in pharmaceutical logistics and supply chain, brought together its entire ecosystem in Paris for In Good Hands by UbiPharm 2026, an exceptional edition held under the theme “Better Together - united for for access to healthcare.” Organised as part of the Group’s 35th anniversary, the event highlighted the uniqueness of the UbiPharm model: a strong, collective and committed organization dedicated to improving access to healthcare.

UbiPharm Group, an expert in pharmaceutical supply chain and logistics across Africa and the overseas territories (DROM), announces that its subsidiary UbiPharm Côte d’Ivoire has been distinguished at the Pan-African ICS Special Awards 2025–2026 ceremony, held on Friday, March 27, 2026, at Ivotel Plateau in Abidjan. This recognition highlights both the track record of a historic Group subsidiary, the commitment of its leadership, and the strength of a collective model dedicated to improving access to healthcare.

Antananarivo, January 20, 2026

The UbiPharm Group announces a new stage in the managerial organisation of its subsidiary in Martinique.

Effective 1 January 2026 :

• Mr. Mathieu ACQUISTO is appointed Managing Director of UbiPharm Martinique.
• Mr. Jean-Baptiste GLUCHOWSKI is appointed Director of Development at D.T. Pharma, a UbiPharm Group subsidiary responsible for managing supply flows to the French overseas departments and regions: Guadeloupe, French Guiana, Martinique and Mayotte.

UbiPharm Martinique, a leading player in pharmaceutical distribution and an expert in health-care logistics and supply chain management in Martinique, announces a leadership transition in continuity with the work accomplished under the direction of Mr. Jean-Baptiste GLUCHOWSKI.

The UbiPharm Group announces a new stage in the managerial organisation of its subsidiary in Gabon.

Effective 2 January 2026:

• Dr Kenneth AWORE is appointed Managing Director of UbiPharm Gabon.
• Dr Osagyevo NGAKA is appointed Director of Lean Management at AuditPharma, a subsidiary of the UbiPharm Group.

UbiPharm Group, a leading player in pharmaceutical distribution and an expert in the logistics and supply chain of healthcare solutions in Africa and the French Overseas Departments and Regions (DROM), announces a new milestone in the governance of UbiPharm Guadeloupe.

Effective 25 November 2025:
• Mr Gérôme GENDREY is appointed Managing Director of UbiPharm Guadeloupe.
• Mr Igor DOHOU steps down from his position as Managing Director.

A trained pharmacist, graduate of the Faculty of Pharmacy of Lille, and holder of a Master’s degree in European and International Regulatory Affairs for Healthcare Products, Mr Gérôme GENDREY has built a rich and diverse professional background in community pharmacy, hospital settings, and the pharmaceutical industry.

Prior to his appointment, he had been serving since January 2025 as Assistant Pharmacist at UbiPharm Guadeloupe. His experience spans management, procurement, and logistics—key assets to support the development of UbiPharm Guadeloupe and to continue strengthening service quality for pharmacists and healthcare partners.

UbiPharm Guinée, a leading wholesaler-distributor of pharmaceutical and parapharmaceutical products in Guinea, is holding its Board of Directors meeting—along with those of the Group’s French entities—from 18 to 21 November in Conakry. On this occasion, the company announces several major investments aimed at strengthening access to healthcare solutions in the country.

Enhanced logistics capacities
As part of the Board meeting, a construction site visit is planned for directors and partners at the new headquarters currently being built. Equipped with a fully air-conditioned warehouse and modern handling tools, the new site will at least double the company’s current storage capacity and improve the preservation conditions of health products. The construction is expected to be completed in the first half of 2026.

At the same time, UbiPharm Guinée confirms the acquisition of a 12-hectare plot of land intended to accommodate new logistics infrastructures in the medium term.

“These future headquarters and expansion projects reflect our commitment to anticipating the needs of the Guinean market and providing our teams with the means to ensure better availability of medicines across the country,” said Mr. Martial TCHOUA, Managing Director of UbiPharm Guinée.

Digitalised payments with Orange Money
UbiPharm Guinée has also integrated merchant payments through Orange Money, replacing manual processes with an automated and secure system. This development reduces order processing times, strengthens traceability, and simplifies daily operations for community pharmacists.

Launch of a digital parapharmacy catalogue and a modernised extranet
Accessible through the UbiPharm Guinée extranet, the digital parapharmacy catalogue will facilitate the consultation and tracking of parapharmaceutical product orders. It will allow pharmacists to view all available parapharmaceutical products in Guinea, access product images and descriptions, and follow new items and promotions in real time.

UbiPharm Guinée’s extranet will also adopt the UbiPharm Group’s new digital identity. Clearer and more ergonomic, it becomes the primary access point for pharmacists to browse the full range of medicines and parapharmaceutical products, track their orders, and access key company information.

The official launch of both platforms is scheduled for early December 2025.

A renewed commitment to healthcare in Guinea
“By modernising our infrastructures, digital tools, and payment solutions, we are strengthening the safety of the pharmaceutical supply chain and our proximity to pharmacists, with the aim of promoting access to healthcare throughout the Guinean territory,” said Mr. Aboubacar KEITA, Chairman of the Board of Directors of UbiPharm Guinée.

Effective 6 October 2025:

Mrs Moinahadidja ABBAS MOUSSA is appointed Managing Director of UbiPharm Mayotte.

Mr Yacine KHORSI is stepping down from his role, after having supported the subsidiary’s development since August 2023.

A qualified pharmacist, graduate of Aix-Marseille II University and holder of a postgraduate diploma in therapeutic education from Paul Sabatier University (France), Mrs ABBAS MOUSSA has been serving since 2024 as Interim Responsible Pharmacist and Exploitation Manager within the subsidiary. She has an in-depth knowledge of local pharmaceutical realities, reinforced by solid experience both in hospitals and community pharmacies.

Her appointment is part of UbiPharm’s ongoing commitment to promoting healthcare in Mayotte and strengthening close ties with pharmacists, institutions, and partners.

Mr Iliace SERALY, Chairman of the Board of Directors of UbiPharm Mayotte, stated:
“This new governance reflects the Board’s and the Group’s determination to reinforce UbiPharm Mayotte’s presence on the island. We have full confidence in Mrs ABBAS MOUSSA to carry forward, with rigour and commitment, our mission: ensuring access to and availability of quality medicines.”

UbiPharm Mayotte and the UbiPharm Group also wish to acknowledge the dedication and resilience of Mr KHORSI, particularly during the management of Cyclone Chido in December 2024.

Both entities extend their best wishes for success to Mrs ABBAS MOUSSA in her new role.

UbiPharm Mayotte, a key player in pharmaceutical distribution, pharmaceutical depository services, and an expert in healthcare logistics and supply chain management in Mayotte, is pleased to announce a new stage in its governance.

Effective 5 October 2025:

Dr Moinahadidja MOUSSA ABBAS has been appointed Managing Director of UbiPharm Mayotte.

Mr Yacine KHORSI is stepping down from his role, after having significantly contributed to the development of the subsidiary over recent years.

A qualified pharmacist, holding degrees from Aix-Marseille II University and Paul Sabatier University (France), Dr MOUSSA ABBAS has been serving as Responsible Pharmacist within the subsidiary since 2024. She has an in-depth understanding of local pharmaceutical realities, reinforced by solid experience in both hospital and community pharmacy settings.

Her appointment is in line with UbiPharm’s ongoing mission: to strengthen healthcare delivery in Mayotte and to reinforce close ties with pharmacists, institutions, and healthcare partners.

Mr Illiace SERALY, Chairman of the Board of Directors of UbiPharm Mayotte, stated:
“This new governance reflects the Board’s and the Group’s determination to reinforce UbiPharm Mayotte’s presence on the island. We have full confidence in Dr MOUSSA ABBAS to uphold, with rigour and dedication, our mission: ensuring access to and availability of quality medicines.”

UbiPharm Mayotte and the UbiPharm Group also wish to acknowledge the commitment and resilience of Mr KHORSI, particularly during the management of Cyclone Chido in 2024.

Both entities extend their best wishes for success to Dr MOUSSA ABBAS in her new role.

About the UbiPharm Group

Present in 15 African countries and 4 French overseas territories, UbiPharm promotes access to healthcare solutions. This supply chain expert operates across five sectors: wholesaler-distributor, distributor, logistics provider, promoter, and stockist. With an innovative model based on 4,000 pharmacist-clients-shareholders and a high-performance, responsible distribution system, UbiPharm is proud to support healthcare stakeholders by building close, mutually beneficial relationships.

UbiPharm

Health at hand, now.

For more information, visit : www.ubipharm.com

About UbiPharm Mayotte

UbiPharm Mayotte is the eighteenth subsidiary of the UbiPharm Group. Established in 2019, the Mahoran subsidiary of UbiPharm is committed to supporting every pharmacist in meeting the needs of their patients by providing solutions that facilitate access to healthcare.

UbiPharm

Health at hand, now.

For more information, please visit: www.ubipharm.com

UbiPharm Cameroun, UbiPharm Cameroon, a leading expert in pharmaceutical logistics and supply chain in Cameroon and a subsidiary of the UbiPharm Group, was honoured at the opening ceremony of PharmaExpo 2025 with the Caducée d’Or Award  for Excellence in the Pharmaceutical Industry.

The award was presented to Mr Gérard MANGOUA on behalf of the UbiPharm Group and received by Dr Jean-Emmanuel LOMPO, General Manager of UbiPharm Cameroon, from Dr NANA Franck, President of the Order of Pharmacists of Cameroon.

Pharmafinance Group, the founding company of the UbiPharm Group, is pleased to announce the appointment of Mrs. Cissé Aïssatou, spouse of Mr. KOFFI, as Chairwoman of the Board of Directors of Pharmafinance, following the General Assembly held on June 25, 2025.

She succeeds Mrs. Justine Sonhon, whose two-year term has come to an end. The Group expresses its deep gratitude to Mrs. Sonhon for her rigorous leadership, inspiring vision, and unwavering commitment to the governance and sustainability of Pharmafinance’s cooperative model.

As the Group celebrates its 35th anniversary, this transition marks a new chapter in the continuity of Pharmafinance’s founding values: boldness, trust, and sharing.

Mrs. Cissé Aïssatou, spouse of Mr. KOFFI, assumes her duties with a sense of responsibility and commitment. Her mandate follows a strong legacy and is driven by a collective ambition to showcase a winning, united Africa.

“I am convinced that the finest chapters of Pharmafinance are yet to be written. And I know we will write them together—with boldness, trust, and sharing.”
- Mrs. Cissé Aïssatou, spouse of Mr. KOFFI

Pharmafinance thus reaffirms its commitment to building, alongside all its shareholders and partners, a future dedicated to the advancement of African pharmacy.

Effective July 1, 2025:

• Mr. William WOUNFACK is appointed Managing Director of 

UbiPharm Guyane.

• Mr. Mathieu ACQUISTO steps down from his role as Managing Director.

UbiPharm Guyane, a key player in pharmaceutical distribution and an expert in pharmaceutical logistics and supply chain in French Guiana, is entering a new chapter in its management, in line with the work accomplished under Mr. Mathieu ACQUISTO's leadership.

A trained pharmacist, Mr. William WOUNFACK has held the position of Sales Director at the subsidiary since 2023. He will leverage his strong experience in the pharmaceutical sector, particularly acquired in Cameroon, to support the continued development of UbiPharm Guyane.

Mr. Mathieu ACQUISTO, who has been with the UbiPharm Group for eight years, led the French Guiana subsidiary since 2019, playing a key role in its growth and performance.

The UbiPharm Group and UbiPharm Guyane thank Mr. ACQUISTO for his exemplary commitment to healthcare professionals and the people of French Guiana. They also extend their congratulations to Mr. WOUNFACK and wish him every success in his new role.

The events organised to mark this anniversary brought together clients, shareholders, and employees for two days filled with learning and emotion.

Day One: a focus on innovation
On June 24, a training session on merchandising was followed by a conference on artificial intelligence.

Day Two: a celebration
On June 25, Pharmafinance held its General Assembly, highlighted by the handover of the Chair of the Board from Mrs. Justine Sonhon to Mrs. Cissé Aïssatou, spouse of Mr KOFFI.

The Assembly concluded with a festive lunch filled with emotion. The ceremony included a rich cultural program:
• The Bak in Gado group captivated the audience with musical storytelling rooted in tradition.
• Virtuoso Narcile Kora added a poetic touch.

Highlight moment
A key moment was the tribute to Mr. Gérard Mangoua, visionary and founder of Pharmafinance. An archival film retracing the first 20 years of the Group rekindled memories and stirred deep emotion. A prominent figure in pharmaceutical development in Côte d’Ivoire and across Africa, Mr. Mangoua was recently awarded the African Pharmacy Excellence Award, recognising his life’s work, leadership, and service to the sector. The trophy was formally presented to client-shareholders. Dr. Emma Angoua, Vice President of the Pharmacists’ Council, speaking on behalf of Dr. Aruna Diarra, delivered heartfelt words of gratitude and recognition.

The celebration concluded joyfully with the traditional cutting of the cake.

Pharmafinance: 35 years of history in service of the values of a winning Africa.

The UbiPharm Group announces a change in the governance of PlanetPharma.

Effective May 22, 2025 

• Mr. Gérard MANGOUA, previously Chief Executive Officer of PlanetPharma, is stepping down from this position while continuing to serve as Managing Director of the UbiPharm Group.
• Dr. Hervé GUESSENND is appointed Chairman of the Board of Directors.
• Dr. Olivier BLÉ succeeds Dr Hervé GUESSENND as Chief Executive Officer of PlanetPharma.
• Dr. Philippe GRILH is appointed Deputy Chief Executive Officer and Head Pharmacist.

A pharmacist by training, Dr. Hervé GUESSENND joined PlanetPharma after serving as Managing Director of UbiPharm Côte d’Ivoire from 1900 to 2005. Over the past 20 years, he has played a key role in PlanetPharma’s growth and structuring while overseeing the company. He leaves behind a strong and sustainable organisation. As Chairman of the Board, he will continue to support the teams with strategic guidance and ensure continuity.

Dr. Olivier BLÉ, brings 30 years of experience with the UbiPharm Group. He notably served as Managing Director of UbiPharm Côte d’Ivoire from 2013 to 2023, before joining PlanetPharma as Deputy Director. He will be supported by Dr. Philippe GRILH, appointed Deputy Chief Executive Officer and Head Pharmacist. He has been with PlanetPharma for over 10 years and previously lead the company’s operations.

These appointments reflect the commitment of PlanetPharma and the UbiPharm Group to ensuring unified, stable, and effective governance in line with their mission.

The new leadership team expresses its gratitude to the Board of Directors for its confidence and reaffirms its shared determination to continue developing PlanetPharma, in close collaboration with employees, partners, and clients; always with the goal of advancing global health.

The UbiPharm Group wishes them every success in their new role.  

The UbiPharm Group is proud to announce that its founder and Managing Director, Mr. Gérard MANGOUA, has been awarded the 2025 Africa Pharmacy Grand Prize for Excellence at the 24th edition of the International Pharmaceutical Forum.

The ceremony took place at the Palais des Congrès in Tunis, attended by numerous key figures from the African pharmaceutical sector. The award was presented by Tunisia’s Minister of Health, Professor Mustapha FERJANI, highlighting the significance of this continental distinction.

This award, granted by the Inter-Order of Pharmacists of Africa (IOPA), recognises over thirty years of commitment, integrity, and vision in advancing healthcare across Africa and the French Overseas Departments and Regions (DROM). It reflects Mr. MANGOUA’s inspiring leadership and honors the daily dedication of UbiPharm’s 2 000 employees who work to make medicines and health products accessible and available to all.

The UbiPharm Group is honoured to announce that its founder and Managing Director, Mr Gérard MANGOUA, has been named "Best Entrepreneur of the Year 2024" for the second time at the Patronat Awards, as part of the 12th CGECI Academy - Confédération Générale des Entreprises de Côte d'Ivoire.

From 3 to 6 July 2024, UbiPharm took part in the 23rd edition of the International Pharmaceutical Forum (FPI) in Lomé, Togo, as an official partner. This major event brought together key players in the African pharmaceutical industry around the theme: "Universal access to healthcare: challenges, issues and prospects for the pharmaceutical sector". The forum, held under the patronage of the Togolese Prime Minister, Mrs Victoire Tomégah-Dogbé, took place at the Hotel 2 Février, Salle Concorde in Lomé, Togo.

During the forum, the Managing Director of UbiPharm Togo, Dr Isdine LAOUROU, the Promotion Director of PlanetPharma, Dr Alassane COULIBALY, the Managing Director of UbiPharm Development, Dr Prosper AWUVE, and the Commercial Director of UbiPharm Togo, Mr Akovi MENSAH spoke at a symposium. They highlighted UbiPharm's commitment to pharmacists and healthcare professionals in Africa, underlining their willingness to work closely together to meet the specific needs of the continent.

UbiPharm members were also joined on the stand by teams from the Ubigen and Labell ranges, demonstrating their commitment to making healthcare accessible and available to people in Africa.

On 9 and 10 March 2024, the UbiPharm team welcomed almost 500 people to the magnificent Cité Internationale Universitaire de Paris for the second edition of its In Good Hands by UbiPharm event. The theme of the event was "anticipation through innovation". Innovation is one of the Group's values.

The event began with a warm welcome from Mrs NTSAME OBAME, Chairman of the Board of Directors of the UbiPharm Group, marking the start of a half-day of innovation and sharing. In his opening speech, Dr Olivier BLÉ, Deputy Director of PlanetPharma, the Group's wholesale export distributor, explained how innovation is the key to transforming pharmaceutical distribution.

Hervé GUESSENND, Deputy Managing Director and Head Pharmacist, and Yann GUIRIEC, Director of General Services and IT at PlanetPharma, then presented a captivating behind-the-scenes video on transtoker, a tool where technology meets precision to ensure the efficient and secure management of essential pharmaceutical products.